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Clinical Heterotransplantation of the Liver 
By GEOFFREY R. GILES, HANS J. Blbe~ndI HIROSHI AMEMIYA, CHARLES G. HALGRIMSON 
AKD THOMAS E. STARZL 
AT THE UNIVERSITY OF COLORADO there 
have been two attempts at orthotopic 
heterotransplantation of chimpanzee livers 
to pediatric recipients suffering from biliary 
atresia. The first of these cases has been 
fully reported, 1 for which reason the fol-
lowing remarks will be confined to observa-
tions about the second patient and his 
animal donor. 
METHODS 
The Recipient 
The child was a 7-month-old male with extra-
hepatic biliary atresia that had been proved by 
previous operation. Blood type was AB +. In ad-
dition to small size at birth (2.5 Kg.), there had 
been a striking failure of growth and develop-
ment. Just before transplantation, the patient's 
weight was 4.2 Kg. of which a significant fraction 
was ascites. During the 7 months of life there 
were recurrent respiratory infections. Pulmonary 
vena-arterial shunts had developed so that the PO" 
on room air was 59 mm. Hg. -
The recipient was first examined at the age of 
4 months. In the ensuing 12 weeks the bilirubin 
ranged from 13.6 to 18 mg. per cent, the alkaline 
phosphatase was 546-835 International units (nor-
mal < 260), and the SCOT consistently was in 
excess of 135 units. Between the ages of 4 and 
7 months, there was deterioration of hepatic func-
tions of synthesis with a reduction of the pro 
thrombin time from 100 to 50 per cent, a decline 
in the total serum protein from 6.0 to 5.5 Cm. 
per cent, and a relluction in the serum albumin 
from 2.9 to 2.6 Gm. per cent. During this 3 
months, a cadaveric donor could not be found. 
'When the child was 6 months old, the thymus 
gbJl(1 was removed through a transverse anterior 
thoracic incision which transected the sternum.2 
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Fig. l.-Aortogram performed on chimpan-
zee donor. ?\ ate anomalous hepatic arterial 
supply with right and left branches originating 
directly from celiac axis. Each kidney was sup-
plied with single renal artery. LHA: Left 
Hepatic Artery; RHA: Right Hepatic Artery; 
GDA: Gastroduodenal Artery; RRA: Right 
Renal Artery; SA: Splenic Artery. 
Recovery from the preliminary procedure was 
uncomplicated. 
The Donor 
Col. Robert I McIver of the Holloman Air 
Force Base primate colony permitted blood to be 
drawn from nine chimpanzees weighing 5 to 15 
Kg. The specimens were used by Dr. Fritz Bach 
of the University of Wisconsin to determine the 
one-way stimulation they cvoked in the child's cul-
tured lymphocytes.4 Two of the donor candidates 
were found to be distinctly less antigenic in this 
system than the other sevcn. Furthermore, the mito-
mycin-treated lymphocytes from these two simian 
donors caused less pronounced reaction by the 
patient's lymphocytes than was produce,1 by a 
panel of human cell lines that were simultaneously 
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tested as controls.4 The animal finally selected 
for donation weighed 6 Kg. It was A plus blood 
type. Before transplantation, an aortogram was 
performed which revealed two hepatic arteries 
originating from the celiac axis (Fig. 1) as well 
as two single renal arteries. 
To perform the foregoing mixed lymphocyte cul-
ture examinations, nearly 50 m!. blood had to be 
taken from the child on two occasions, or an 
estimated 15 per cent of blood volume both 
times. The blood was replaced by two transfu-
sions with possibly tragic consequences as will 
be discussed later. 
ReCipient Immunological Studies 
The competence of the recipient peripheral 
lymphocytes was evaluated before and after thy-
mectomy by their ability to undergo blast trans-
formation when exposed in tissue culture to 
phytohemagglutinin,3 mitomycin-killed lympho-
cytes from nonrelated people and Candida albicans 
extracts.5 \Vith each kind of test, normal responses 
were obtained. 
Scrum titers of heterohemagglutinins against the 
red cells of the actual chimpanzee donor were 
studied in the recipient before and after trans-
plantation. Similarly, leukoagglutinins6 and lym-
phocytotoxins7 were measured against the periph-
eral white cells of the animal. In addition, whole 
complement and complement components 1 q, 
3, 4 and 5 were quantitated. 8,9 Direct Coomb's 
tests10 were performed on the recipient red cells 
with the aid of an antiserum raised in rabbits 
immunized by four injections of pooled whole 
chimpanzee serum. 
Coagulation Studies 
Before, during, and after transplantation repeat-
ed arterial samples were taken and analyzed for 
platelets, euglobulin lysis time, thromhin time, 
prothrombin time, partial thromboplastin time, 
fibrinogen, prothrombin, accelerator globulin, anti-
hcmophilic globulin, plasma thromboplastin com-
ponent, and fibrin split products. The methodology 
of these determinations was the same as in two 
recent reports from our laboratories.11,12 
The Operation 
The operation was performed on December 3, 
1969, through a long bilateral subcostal incision. 
The spleen was mobilized and the splenic artery 
and vein skeletonized. Then, splenectomy was per-
formed. Simultaneously, the left chimpanzee kid-
ney was removed, infused through its artery with 
a special chilled electrolyte solution1 to remove 
all blood, and its renal artery and vein anasto-
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mosed end-to-end to the splenic artery and vein. 
The right chimpanzee kidney was excised 3 hours 
later and its artery anastomosed end-to-end to a 
branch of the hepatic artery in the hilum of the 
liver. The renal vein of the second heterograft 
was connected end-to-side to the recipient portal 
vein. Thus, venous outflow from both the renal 
heterografts was directed into the relatively high 
pressure splanchnic system (20-25 mm. Hg). 
Using a standard orthotopic proccdure,1 the 
recipient liver was now excised and replaced with 
a heterograft approximately 5% hours after the first 
exposure to the chimpanzee kidney. The ischemia 
time of the transplanted liver was 62 minutes in-
cluding the period necessary to cool it by intra-
portal infusion with the same kind of solution 
used earlier for the kidneys. Just before revas-
cularization the recipient was given 3.4 mg./Kg. 
intravenous heparin. Biliary drainage was estab-
lished with a cholecystoduodenostomy. 
RESULTS 
Clinical Observations 
The first renal heterograft, which was 
anastomosed onto the splenic pedicle, bc-
came pink after revascularization and ex-
creted a few drops of urine. However, 
within 5 minutes the organ turned cyanotic 
and remained so until it was removed 3 
hours later. The second kidney, which was 
inserted high in the hepatic hilum, was 
pink for more than half an hour before 
suffering the same fate as the first organ. 
Even preceding this part of the operation 
and continuing throughout, the patient had 
a severe metabolic acidosis, requiring con-
stant correction with sodium bicarbonate 
and THAM. Ultimately the consequcnce of 
this corrective therapy was severe hyperna-
tremia (maximum serum Na 167 mEq./L.). 
When the hepatic heterograft was re-
arterialized it seemed to have a very poor 
blood supply with the surface of the organ 
being distinctly cyanotic. However, after 
the subsequent restoration of the portal 
venous flow, thc liver became homo-
genously pink and was not perceptibly dif-
ferent than a good homograft at a similar 
stage of the procedure. Excretion of bile 
into the opened gall bladder was quite 
evident at this time. 
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For the next hour the child's hemody-
namic condition was excellent despite the 
difficulty in control of metabolic acidosis 
described earlier. It seemed that a real test 
of the heterotransplantation was going to 
be possible until about an hour later when 
the blood pressure fell to 60 mm. Hg and 
the pupils became constricted. The abdomi-
nal incision was quickly closed. Despite ef-
forts at resuscitation, it was never possible 
to restore a normal blood pressure. The 
child died 26 hours after the heterotrans-
plantation without having awakened. Dur-
ing the entire postoperative period he was 
anuric. 
After the transplantation, the total biliru-
bin fell to 2.3 mg. per cent. The SCOT 
was always below 144 International units 
but the alkaline phosphatase rose to 1060 
International units. At autopsy, there was 
approximately 200 ml. of free blood in the 
peritoneal cavity. The liver had a normal 
color and the vascular anastomoses were all 
patent. Histologically, there was essentially 
no evidence of hepatocellular damage. A 
few pyroninophilic lymphocytes were in the 
portal tracts. In the extrahepatic organs, the 
most significant findings were severe edema 
of the brain and multiple pulmonary em-
boli (diagnosed by microscopy) scattered 
throughout both lungs. 
Immunologic Studies 
Six weeks before heterotransplantation, 
the recipient's serum did not contain anti-
donor lymphocytotoxins. By the time of op-
eration, it was later shown that cytotoxins 
had appeared, possibly as a consequence 
of accidental sensitization by the two 
homologous transfusions that had been 
made nccessary some weeks earlier by the 
withdrawal of large quantities of blood for 
testing. The level of the systemic lympho-
cytotoxins was not affected by transplan-
tation of the first kidney. However, after 
revascularization of the second chimpanzee 
kidney and then the liver, all detectable 
lymphocytotoxic activity disappeared from 
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Fig. 2.-Antibodies in serum of recipient 
arterial blood before, during and after trans-
plantation of two successive kidneys and liver 
from same chimpanzee donor. 
the arterial blood (Fig. 2). Pre-existing 
antidonor leukoagglutinins and hetero-
hem agglutinins in the arterial blood were 
also reduced and finally eliminated either 
by the transplantation of the preliminary 
kidneys, or else after revascularization of 
the liver (Fig. 2). 
Before operation, the rabbit antiserum 
raised against chimpanzee serum caused 
agglutination of recipient red cells at a titer 
of 1:500. This result was not changed by 
revascularization of the two preliminary 
renal heterografts but within an hour after 
revascularization of the liver the titer of the 
direct Coombs test rose to 1:2000 (Fig. 2). 
Conceivably the increase in titer may have 
been due to coating of the red cells with 
chimpanzee protein either synthesized by 
or alternatively washed out of the newly 
revascularized liver. 
Complement levels in the systemic blood 
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Table I.-Whole-serum Complement and Complement Components Measured During 
Revascularization of Chimpanzee Kidneys and Liver 
Whole-serum 
Complement Complement Components mg./ml. 
CH50 units/m!. Clq C4 C3 C5 
Day prior to heterotransplantation 
2 minutes before first kidney vascularized 
90 minutes after first kidney 
2 minutes before second kidney 
60 minutes after second kidney 
2 minutes before liver vascularized 
60 minutes after liver vascularized 
4 hours after liver vascularized 
16 hours after liver vascularized 
PLATELETS 
(xI0·3) 
WBC 
Exl~F 
FIBRINOGEN 
• (mg"!o) 
PROTHROMBIN 
("!o) 
FACTOR :lL 
("!o) 
FACTOR = 
("!o) 
FACTOR IX: 
("!o) 
PTT 
(soc.) 
ELT 
(min.) 
FSP 
("'9%l 
HOURS 
Fig. 3.-Measures of clotting factors, fib-
rinolytic indices and formed blood elements 
before and after transplantation of chimpanzee 
organs. Total body heparinization was carried 
out before liver transplantation, making im-
possible subsequent determination of pro-
thrombin, factor V, factor IX and euglobulin 
lysis time. 
33 
28 
29 
30 
24 
24 
16 
0 
0 
.137 .366 1.84 .087 
.127 .240 1.32 .084 
.148 .318 1.36 .076 
.167 .336 1.32 .084 
.11S .318 1.04 .059 
.11S .336 LOS .065 
.125 .258 .90 .055 
.046 .138 .42 .032 
.049 .204 .42 .030 
were unaffected by the first kidney anu 
showed moderate falls with the second. 
However, once the liver was vascularized, 
the level of whole complement fell so that 
at 4 hours, it was not detectable in the 
circulating blood and the four components 
tested were all considerably reduced 
(Table 1). 
Coagulation Studies 
At the outset, all of the clotting studies 
shown in Fig. 3 as well as the thrombin 
time and prothrombin time were normal or 
nearly normal. After revascularization of the 
first chimpanzee kidney, a striking series of 
transient changes occurred (Fig. 3). There 
were reductions in the arterial platelets, 
fibrinogen, prothrombin and accelerator 
globulin (V) as well as shortening of the 
euglobulin lysis time (EL T) and the ap-
pearance of fibrin split products. At about 
the same time, there was increased activity 
of antihemophilic globulin ( VIn) and 
accompanied by marked shortening of the 
partial thromboplastin time. Taken together 
the foregoing findings were interpreted as 
indicating intravascular coagulation (prob-
ably triggered within the transplant) and 
hypercoagulability. The alterations were re-
turning towards normal by the time of the 
second renal heterotransplantation and 
were not made worse with restoration of 
the blood supply of this kidney. 
Before the liver was inserted, 3.4 mg./Kg. 
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heparin were given making further meas-
urement impossible of several of the pa-
rameters (Fig. 3). Those which could be 
followed were not much affected by hepatic 
vascularization (Fig. 3). Mter the single 
dose of heparin, no clots could be obtained 
with the determinations of the thrombin, 
prothrombin, and partial thromboplastin 
time. The anticoagulant in the patient's 
plasma was thermostable and completely 
neutralizable in vitro with protamine sul-
fate (0.05 mg./ mI.), one and 20 hours later. 
However, two intravenous doses of prota-
mine sulfate 12 (7 mg.) and 19 hours (10 
mg.) after the initial heparin dose failed 
to neutralize the heparin effect in the pa-
tient. 
DISCUSSION 
The circumstances under which this and 
the previous hepatic heterotransplantation1 
were performed were similar. In both cases, 
the condition of the recipients deteriorated 
markedly while a search was being con-
ducted for cadaveric donors. Ultimately, 
the use of a chimpanzee organ was viewed 
as a desperate therapeutic effort. If hetero-
grafts can be made to work, their most 
urgent need in the future will probably be 
to replace organs such as the liver and 
heart, for which long term interim function 
cannot be provided by machines or instru-
ments analogous to the artificial kidney. 
The special feature of the heterotrans-
plantation herein reported was the effort 
to deplete preformed heterospecific anti-
bodies before arrival of the definitive 
hepatic graft. This was to be done by pre-
liminary transplantation of the chimpan-
zee's kidneys. The rationale for such an ap-
proach was based upon the work of Clark,13 
Linn,14 and ourselves15 with difficult species 
combinations including rabbit to dog, pig 
to dog, and dog to pig heterotransplanta-
tions and upon the work of Simpsonll who 
employed this technique of antibody ab-
sorption for homotransplantation to sensi-
tized canine recipients. 
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In the relatively easy chimpanzee-to-man 
species combination, it has not actually 
been established that such a preliminary 
"screening" procedure is useful. With the 
early experience of Reemstma and DevVitt 
and their associates,16 the only preformed 
heterospecific antibody that was ever dem-
onstrated in patients was a heat labile 
hemagglutinin that did not seem to have 
much avidity, if any, for nucleated chim-
panzee cells. Nevertheless, the protocol 
followed in our recipient assumed for rea-
sons discussed elsewherel,ll) that such pre-
existing antibodies were in fact significant. 
Unfortunately, an additional potentially 
morc serious cytotoxic antibody developed 
in the hepatic recipient of this report be-
tween the time when the simian donor was 
selected and the actual transplantation. It 
is probable that this lymphocytotoxin was 
induced by blood transfusion. If so, the 
situation was converted to the same excep-
tionally dangerous one as with homotrans-
plantation to a presensitized recipient.ll•12.11 
Consequently, the case probably did not 
represent a fair test of the heterograft sys-
tem being examined. 
In fact, certain changes in the liver re-
cipient were more consistent with observa-
tions made in both dogsll and humansl2•17 
who had preformed anti donor antibodies 
and whose renal homo grafts underwent 
rapid rejection than with what is known 
about the behavior of chimpanzee hetero-
grafts in man. For example, the preliminary 
renal heterografts appeared to be rejected 
in a hyperacute fashion that would not have 
been expected from the earlier reported ex-
perience of Reemstma.16 At this time there 
was evidence of absorption of several kinds 
of antibodies by the kidneys. Subsequently, 
the new liver continued this absorption 
along with complement depletion. There 
were also highly significant changes of 
various clotting measurements indicating 
intravascular coagulation. The role of coag-
lation in hyperacute rejection of both homo-
graftsll.12.17 and heterografts18 has been the 
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subject of several recent articles. It is con-
ceivable that the thrombi distributed exten-
sively throughout both lungs were the con-
sequence of such an immunologically 
mediated coagulopathy. 
In spite of the foregoing evidence, it can-
not be stated with certainty that the tragic 
outcome in this case had a strictly immuno-
logic etiology. It could be argued just as 
persuasively that the patient died from a 
preexisting and uncorrected metabolic ab-
normality consisting first of metabolic acido-
sis compounded later by hypernatremia. 
The sudden intraoperative vascular collapse 
and the subsequent neurologic deteriora-
tion could have been on this basis rather 
than because of a hyperacute hepatic re-
jection. Indirect evidence in favor of the 
nonimmunologic interpretation was the fact 
that a number of liver functions were well 
maintained postoperatively and that the 
graft had little evidence of injury at the 
time of autopsy one day later. 
SUMMARY 
A 7-month-old child with extrahepatic 
biliary atresia was treated by orthotopic 
transplantation of a chimpanzee liver after 
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preliminary revascularization in the re-
cipient of both kidneys from the same ani-
mal donor for the purpose of depleting 
preformed heterospecific antibodies. Un-
fortunately, there was evidence that the 
child was presensitized to white cell anti-
gens by preoperative blood transfusions 
with the consequent development of 
lymphocytotoxic antibodies that reacted 
with donor tissues. When the chimpanzee 
kidneys were revascularized in the re-
cipient, they appeared to be hyperacutely 
rejected. The liver did not suffer the same 
fate but the child failed to awaken from 
anesthesia and died one day later. It was 
not possible to determine if the death was 
caused by metabolic complications that are 
common with this procedure even when 
homo grafts are used, if the employment 
of a chimpanzee liver had any specific role 
in the tragic outcome, or if a presensitized 
state was an important adverse factor. 
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